This drug information is developed by an intensive process of compiling approved product label information on drug use and also collecting and analyzing publicly available data on each drug from research studies and clinical reports.
Careful attention is paid to differentiating species-specific information.
Each draft chapter or monograph is then put through a review process that includes USP Veterinary Medicine Advisory Panel members, regulatory representatives, pharmaceutical manufacturers, ad hoc specialists, and public review. The resulting resource provides practitioners with a wide range of information about the use of each particular medication in animals. If evidence is limited or conflicting, label and extra-label uses may be listed as Acceptance not established indications. Drug uses that are not currently considered scientifically sound are listed under an Unaccepted heading. The goal of each monograph is to provide information to aid practitioners in making therapeutic decisions.